Humacyte Completes Enrollment in Phase 2/3 Trial of Human Acellular Vessel for Vascular Trauma Repair

Press/Media

Period	26 Jul 2023

Media coverage

Title	Humacyte Completes Enrollment in Phase 2/3 Trial of Human Acellular Vessel for Vascular Trauma Repair
Media name/outlet	Endovascular Today
Country/Territory	United States
Date	26/07/23
URL	https://evtoday.com/news/humacyte-completes-enrollment-in-phase-23-trial-of-human-acellular-vessel-for-vascular-trauma-repair?c4src=home
Persons	Todd Rasmussen